tsh biopharmoration Ltd (8432) — Financial Flexibility Index
tsh biopharmoration Ltd (8432) has a Financial Flexibility Index of 0.17x as of June 2025. Free cash flow of NT$45.82 Million (operating CF NT$42.55 Million minus capex NT$3.27 Million) represents 0% of total liabilities (NT$273.54 Million). Check 8432 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
tsh biopharmoration Ltd Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for tsh biopharmoration Ltd across 8 annual periods. For the full cash flow conversion analysis, see 8432 cash flow metrics.
Annual Financial Flexibility Index for tsh biopharmoration Ltd (2017–2024)
Year-by-year free cash flow to debt coverage for tsh biopharmoration Ltd. Explore tsh biopharmoration Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.85x | NT$186.51 Million | NT$183.77 Million | NT$219.22 Million | ▲ +188.3% |
| 2023 | 0.30x | NT$39.43 Million | NT$33.87 Million | NT$133.63 Million | ▲ +23.7% |
| 2022 | 0.24x | NT$53.08 Million | NT$34.35 Million | NT$222.46 Million | ▼ -70.4% |
| 2021 | 0.81x | NT$69.09 Million | NT$68.71 Million | NT$85.80 Million | ▲ +493.1% |
| 2020 | 0.14x | NT$13.99 Million | NT$11.61 Million | NT$103.04 Million | ▼ -79.4% |
| 2019 | 0.66x | NT$91.64 Million | NT$88.65 Million | NT$138.79 Million | ▼ -4.1% |
| 2018 | 0.69x | NT$68.50 Million | NT$62.62 Million | NT$99.44 Million | ▲ +8.6% |
| 2017 | 0.63x | NT$85.70 Million | NT$81.13 Million | NT$135.08 Million | — |